Cargando…
Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas
Dormant cancer cells are starvation-resistant leading to problems in the management of cancer. In renal cell carcinomas (RCCs), starvation-resistant cells are resistant to various currently available therapies. However, targeting hypoxia inducible factor 2-alpha (HIF2-alpha) induces cell death in do...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955402/ https://www.ncbi.nlm.nih.gov/pubmed/29796174 http://dx.doi.org/10.18632/oncotarget.25214 |
_version_ | 1783323704188469248 |
---|---|
author | Isono, Takahiro Chano, Tokuhiro Yoshida, Tetsuya Kageyama, Susumu Kawauchi, Akihiro Yonese, Junji Yuasa, Takeshi |
author_facet | Isono, Takahiro Chano, Tokuhiro Yoshida, Tetsuya Kageyama, Susumu Kawauchi, Akihiro Yonese, Junji Yuasa, Takeshi |
author_sort | Isono, Takahiro |
collection | PubMed |
description | Dormant cancer cells are starvation-resistant leading to problems in the management of cancer. In renal cell carcinomas (RCCs), starvation-resistant cells are resistant to various currently available therapies. However, targeting hypoxia inducible factor 2-alpha (HIF2-alpha) induces cell death in dormant-like/starvation-resistant RCCs. This study showed that the apoptotic cell death caused by tumor necrosis factor (TNF)-related apoptosis-induced ligand (TNFSF10/TRAIL) was attenuated by CASP8 and FADD-like apoptosis regulator (CFLAR/c-FLIP) following HIF2-alpha activation, despite the high expression of TRAIL in such RCCs. Knockdowns of TRAIL averted apoptotic cell death caused by HIF2-alpha inhibition in starvation-resistant RCCs. Knockdowns of both HIF2-alpha and c-FLIP augmented apoptotic cell death, whereas overexpression of c-FLIP completely averted apoptosis. In addition, high abundance of TRAIL was correlated with poor prognosis in patients with RCC, suggesting that TRAIL, followed by HIF2-alpha and c-FLIP, play a role in the survival and/or progression of malignant RCCs. |
format | Online Article Text |
id | pubmed-5955402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-59554022018-05-24 Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas Isono, Takahiro Chano, Tokuhiro Yoshida, Tetsuya Kageyama, Susumu Kawauchi, Akihiro Yonese, Junji Yuasa, Takeshi Oncotarget Research Paper Dormant cancer cells are starvation-resistant leading to problems in the management of cancer. In renal cell carcinomas (RCCs), starvation-resistant cells are resistant to various currently available therapies. However, targeting hypoxia inducible factor 2-alpha (HIF2-alpha) induces cell death in dormant-like/starvation-resistant RCCs. This study showed that the apoptotic cell death caused by tumor necrosis factor (TNF)-related apoptosis-induced ligand (TNFSF10/TRAIL) was attenuated by CASP8 and FADD-like apoptosis regulator (CFLAR/c-FLIP) following HIF2-alpha activation, despite the high expression of TRAIL in such RCCs. Knockdowns of TRAIL averted apoptotic cell death caused by HIF2-alpha inhibition in starvation-resistant RCCs. Knockdowns of both HIF2-alpha and c-FLIP augmented apoptotic cell death, whereas overexpression of c-FLIP completely averted apoptosis. In addition, high abundance of TRAIL was correlated with poor prognosis in patients with RCC, suggesting that TRAIL, followed by HIF2-alpha and c-FLIP, play a role in the survival and/or progression of malignant RCCs. Impact Journals LLC 2018-05-01 /pmc/articles/PMC5955402/ /pubmed/29796174 http://dx.doi.org/10.18632/oncotarget.25214 Text en Copyright: © 2018 Isono et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Isono, Takahiro Chano, Tokuhiro Yoshida, Tetsuya Kageyama, Susumu Kawauchi, Akihiro Yonese, Junji Yuasa, Takeshi Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas |
title | Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas |
title_full | Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas |
title_fullStr | Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas |
title_full_unstemmed | Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas |
title_short | Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas |
title_sort | abundance of trail attenuated by hif2α and c-flip affects malignancy in renal cell carcinomas |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955402/ https://www.ncbi.nlm.nih.gov/pubmed/29796174 http://dx.doi.org/10.18632/oncotarget.25214 |
work_keys_str_mv | AT isonotakahiro abundanceoftrailattenuatedbyhif2aandcflipaffectsmalignancyinrenalcellcarcinomas AT chanotokuhiro abundanceoftrailattenuatedbyhif2aandcflipaffectsmalignancyinrenalcellcarcinomas AT yoshidatetsuya abundanceoftrailattenuatedbyhif2aandcflipaffectsmalignancyinrenalcellcarcinomas AT kageyamasusumu abundanceoftrailattenuatedbyhif2aandcflipaffectsmalignancyinrenalcellcarcinomas AT kawauchiakihiro abundanceoftrailattenuatedbyhif2aandcflipaffectsmalignancyinrenalcellcarcinomas AT yonesejunji abundanceoftrailattenuatedbyhif2aandcflipaffectsmalignancyinrenalcellcarcinomas AT yuasatakeshi abundanceoftrailattenuatedbyhif2aandcflipaffectsmalignancyinrenalcellcarcinomas |